Please select your preferred language.
00 : 54 : 32
TECARTUS ACE MCL webinar 2026
01 : 27 : 10
The power of timely and reliable CAR T treatment for eligible patients with R/R DLBCL at 2L
00 : 01 : 03
Discover Kite's in-house viral vector production
00 : 12 : 45
00 : 12 : 59
Successful CAR-T cell therapy requires a close collaboration between referring hospitals and the CAR-T reference centre/BE-TEC-0059
00 : 13 : 24
CAR-T cell therapy as second line treatment for patients with diffuse large B cell lymphoma/BE-TEC-0059